Burst Biologics Spinal Fusion Study
Burst Biologics received IRB approval for a U.S. prospective clinical study of BioBurst cellular allograft in spinal fusion....
Mar 28, 2017,
Burst Biologics Spinal Fusion Study
First U.S. Surgery with MIS Z-Pedicle Screw System in an Open Procedure
Z-Medical announced completion of the first open procedure to employ the MIS Z-Pedicle Screw system in the U.S....
Mar 24, 2017,
Member Question: Additively-Manufactured Product Launches
Earlier this year, an ORTHOWORLD Member asked us: What portion of new products introduced in joint reconstruction and spine are...
Mar 24, 2017,
Alphatec Announces $18.9 Million Private Placement
Alphatec Spine entered into a definitive securities purchase agreement to raise ~US $18.9MM in a private placement....
Mar 23, 2017,
Additive Orthopaedics Launches Clinical Study of 3D Printed Bone Segments
Additive Orthopaedics commenced a multi-center clinical study to measure bone in-growth into 3D-printed bone segments....
Mar 23, 2017,
One-Year Study Results: Percutaneous Application of the IlluminOss System
Study results indicate that percutaneous intramedullary fixation provided by IlluminOss Medical’s light curable monomer system can provide stabilization of fractures without open...
Mar 23, 2017,
AAOS Recap: Robots, Bundles and Outpatient Procedures
Discussions at the 2017 AAOS Annual Meeting were dominated by the new era of joint reconstruction procedures and three prevailing...
Mar 23, 2017,
What Can We Expect in Joint Reconstruction Ten Years From Now?
What's on the horizon for joint reconstruction? We posed that question to Orhun Muratoglu, Ph.D., a materials expert, as well...
Mar 23, 2017,
First Mont Blanc MIS Procedure in the US
Spineway announced completion of the first minimally invasive surgery in the U.S. using the Mont Blanc MIS line....
Mar 22, 2017,
New Joint Reconstruction Products Top AAOS 2017 Highlights
Did you miss a product clearance or launch announced at AAOS? Here we've compiled a list of highlights by market...
Mar 22, 2017,
Loading new posts...
No more posts
